Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 ... 7 8 9 10 presentations: 1 to 25 of 235
Design and Method Workshop for Clinical Trials and Population Studies, Part 1: Design and Implementation of Innovative Clinical Trials for Targeted Therapies
Molecular diagnostics: Interface with targeted therapeutics clinical trials
Russell R. Broaddus
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Design and Method Workshop for Clinical Trials and Population Studies, Part 1: Design and Implementation of Innovative Clinical Trials for Targeted Therapies
Enrichment and adaptive enrichment designs for clinical trials with targeted therapies
Richard M. Simon
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Design and Method Workshop for Clinical Trials and Population Studies, Part 1: Design and Implementation of Innovative Clinical Trials for Targeted Therapies
We learn as we go: Bayesian adaptive designs for efficient and flexible clinical trials
J. Jack Lee
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Design and Method Workshop for Clinical Trials and Population Studies, Part 1: Design and Implementation of Innovative Clinical Trials for Targeted Therapies
Perspectives on trial designs: The past, present, and future of the targeted therapy development
Sumithra J Mandrekar
Mayo Clinic, Rochester, MN, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Optimizing Drug Discovery: Insights on an Important Process
Introduction
Michael J. Luzzio
Biogen Idec, Inc., Cambridge, MA, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Optimizing Drug Discovery: Insights on an Important Process
  •  
  • Permission not
    granted for presentation
  •  
  •  
Discovery of a potent covalent mutant-selective EGFR inhibitor: The journey from high throughput screening to EGF816
Gerald Lelais
Genomics Institute of the Novartis Research Institute, San Diego, CA, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Optimizing Drug Discovery: Insights on an Important Process
  •  
  • Permission not
    granted for presentation
  •  
  •  
Lead optimization through modulation of physicochemical properties: A case study in the discovery of novel CDK9 inhibitors
Yunsong Tong
AbbVie Inc., North Chicago, IL, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Optimizing Drug Discovery: Insights on an Important Process
Discovery of pan-notch inhibitors as anticancer agents
Ashvinikumar V. Gavai
Bristol-Myers Squibb Co., Princeton, NJ, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Human Biospecimens in Cancer Research: Do You Know Where Your Samples Came From and Where They Have Been? Are You Analyzing Artifact instead of Biology?
“Garbage in” and cancer research
Carolyn Compton
Arizona State University, Scottsdale, AZ, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Human Biospecimens in Cancer Research: Do You Know Where Your Samples Came From and Where They Have Been? Are You Analyzing Artifact instead of Biology?
What a genomicist needs to know about clinical biospecimens
Kenneth Bloom
GE Healthcare, Aliso Viejo, CA, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Human Biospecimens in Cancer Research: Do You Know Where Your Samples Came From and Where They Have Been? Are You Analyzing Artifact instead of Biology?
  •  
  • Permission not
    granted for presentation
  •  
  •  
Human biospecimens for in vitro diagnostics: Regulatory considerations
Yun-Fu Hu
FDA, Silver Spring, MD, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Human Biospecimens in Cancer Research: Do You Know Where Your Samples Came From and Where They Have Been? Are You Analyzing Artifact instead of Biology?
Sample suitability for studies with cancer proteomics
Christopher Kinsinger
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Human Biospecimens in Cancer Research: Do You Know Where Your Samples Came From and Where They Have Been? Are You Analyzing Artifact instead of Biology?
  •  
  • Free
  • Unknown permission
    for presentation
  •  
  •  
The Impact of Tissue Pre-Analytics on Drug Development
Steven Potts
Flagship Biosciences, Inc., Westminster, CO, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Imaging the Tumor Niche and Therapeutic Responses
  •  
  • Permission not
    granted for presentation
  •  
  •  
Introduction: New techniques for imaging cancer in the niche
Margaret C. Frame
Univ. of Edinburgh, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Imaging the Tumor Niche and Therapeutic Responses
Imaging drug-tolerant micro-environments
Erik Sahai
Cancer Research UK, London, United Kingdom
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Imaging the Tumor Niche and Therapeutic Responses
  •  
  • Permission not
    granted for presentation
  •  
  •  
Imaging immune-tumor interactions
Matthew F Krummel
UCSF, San Francisco, CA, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Imaging the Tumor Niche and Therapeutic Responses
Long term imaging of the perivascular niche in metastasis and therapy responses
Frank A Winkler
German Cancer Research Ctr., Heidelberg, Germany
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Liquid Biopsy Biomarkers
Circulating cell free DNA and cancer
Alain R Thierry
INSERM U896, Montpellier, France
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Liquid Biopsy Biomarkers
  •  
  • Permission not
    granted for presentation
  •  
  •  
Circulating miRNAs
Muneesh Tewari
University of Michigan Medical School, Ann Arbor, MI, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Liquid Biopsy Biomarkers
  •  
  • Permission not
    granted for presentation
  •  
  •  
Circulating tumor cell biopsies
Caroline Dive
CRUK Manchester Institute, Manchester, United Kingdom
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Liquid Biopsy Biomarkers
Malignant stem cells in the circulation
Andreas Trumpp
German Cancer Research Ctr., Heidelberg, Germany
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Methods for Pharmacogenomics Discovery and Interpretation
Introduction
Angelique Whitehurst
UT Southwestern Simmons Comp. Cancer Center, Dallas, TX, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Methods for Pharmacogenomics Discovery and Interpretation
Statistical challenges and opportunities in pharmacogenetics
Alison Motsinger-Reif
North Carolina State University, Raleigh, NC, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Methods for Pharmacogenomics Discovery and Interpretation
Identification of genomic predictors of drug response by high-throuhgput cell line screening
Cyril Benes
Massachusetts General Hospital Cancer Center, Charlestown, MA, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Methods for Pharmacogenomics Discovery and Interpretation
Clinical implications of cancer genome sequencing
Ramaswamy Govindan
Washington Univ. School of Medicine, St, Louis, MO, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 ... 7 8 9 10 presentations: 1 to 25 of 235